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Presentation by Brad Fiske MS III
Mentors/PI’s: Cristina Smina MD & Giselle Volney MD
My role in this project:
• This project (and the research writeup from which this presentation is derived) was developed by 
Drs. Cristina Smina MD & Giselle Volney MD PGY-3 of the Norwalk Hospital Internal Medicine 
Residency Program. 
• My role as a medical student was/is to help convert the original research protocol into an 
implementable quality improvement project at the Norwalk Community Health Center.
• Moving forward, I will be helping with in-person measurements at the clinic and any other tasks 
the PI’s listed above need help with.
• For this FM clerkship project, my deliverable is the QI writeup from the original proposal.
• This PowerPoint is an abbreviated version of the QI writeup.  QI writeup itself will be emailed to 
clerkship staff as a deliverable. 
Why use waist 
circumference as a 
vital sign?
Obesity is associated with increased risk of cardiovascular disease (CVD) & type 2 
diabetes mellitus (DM II); the prevalence of obesity has increased worldwide
throughout the last three decades 1. 
•
High levels of visceral adipose tissue (VAT) are associated with chronic 
inflammation and conditions such as metabolic syndrome, insulin resistance, 
and CVD as well as breast, colorectal, & prostate cancers 2.  
•
BMI as a measurement does not account for variations in lean mass vs. adipose 
tissue, nor does BMI distinguish between subcutaneous & visceral fat stores.  
Thus, the amount of VAT present may differ radically within a narrow range of 
BMI values. 
•
Waist circumference (WC) measurements have been demonstrated to provide 
additive information for predicting all-cause mortality & CVD-related mortality 
in obese patients; it is also a more accurate measurement of VAT stores than is 
BMI1,3. 
Elevated waist circumference: 40” (102 cm) + in men; 35” (88 cm) + in women (6)
Cost of comorbidities 
associated with VAT
• According to CDC: obesity-related 
medical costs in 2008 dollar value: 
$147 billion
• Associated costs in productivity 
loss = $3.38 billion  $6.38 billion
(CDC)
• Costs are projected to increase to 
be upwards of $65 billion/year in 
the US by 2030 (5)
Community 
perspective
“I think it’s a good idea---I wouldn’t 
be opposed to having it done at 
annual physicals or other routine 
appointments”- CJB; office staff at 
local Dr.’s office
“I would be open to having it (WC 
measurement) done when I go to 
the doctor’s (office).  A lot of the life-
insurance paperwork we need to fill 
for patients already requires this 




- Male & female patients with a BMI between 25-34.9 who have upcoming visits will 
be included in the study. 
•
- During the patient’s first visit after enrollment, medical assistants (MA) will perform 
the WC measurement (inches).  The MA will also instruct the patient on how to take 
their own WC.  A hand-out with graphic (Fig.1) will be used to assist with instruction 
and will be given to patient prior to their leaving the office. The patient will also be 
provided a log where they can keep track of their measurements. 
•
- WC obtained by the MA on initial visit will be entered into the EMR as a vital sign 
with the BMR. 
•
- Patients will be asked to measure their WC every month and to keep a log of these 
measurements on the provided document. 
•
- A follow-up telephone or in-person visit with a resident will occur every three 
months throughout a 12-month period. The patient will be assigned the same 
resident provider (or a provider from the same group) to ensure continuity of care. 
•
o In-person visits at the 3- & 9-month marks will be “non-billable”
•
o Telephone follow-ups conducted at the other three-month intervals will be 
“non-billable” as well. 
•
o These visits will pertain strictly to management of BMI & WC; no other 
medical concerns will be addressed during these visits. 
•
o At each visit, patients will be educated on the “Weight Loss & Waist Loss” to 
further solidify their understanding and to encourage them in adopting the 
necessary lifestyle changes. 
 Resident providers will spend time educating patients on 
recommended diet & physical activity per current 
recommendations. 
 Patients will be offered a nutrition consult. 
•
o No weight loss drugs will be used. 
Waist Circumference Protocol (Fig. 1) :
(1) Identify the top of iliac crest on both sides: 
this is where the measuring tape will be 
placed. 
(2) Stand straight with feet within shoulder 
distance apart & weight evenly distributed. 
(3) Hold the tape snug across the abdomen  at 
the end of a normal breath; repeat this 
measurement twice (i.e. repeat step 3 to get 
two measurements)
(4) If measurements are more than 0.4” 
(approx. 3/8”) apart, repeat step 3 until 
measurements fall within 3/8” of each 
other. 
(5) Once measurements are taken, calculate the 
average and record the average calculated 
as the WC measurement (in inches).
Proposed results 
collection:
- Measurements of WC, BMI, and weight 
will be exported into an excel spread 
sheet. A graph showing the trends of 
their measurements over the 12-month 
period will be created and provided to 
the patient. 
- The delta of patients’ weight and waist 
measurements will be analyzed using 





- A survey at the end of the 12-month 
period will be administered to every 
patient who completed the program. This 
survey will provide metrics on:
o Percentage of patients who found 
the campaign helpful in encouraging 
lifestyle changes as it relates to diet 
and exercise.
o Percentage of patients who found 
campaign helpful in achieving 
weight-loss and waist-loss goals.
o Percentage of clinic staff who found 





IMO, this is a great start 
as a screening patients 
prior to their developing 
sequelae from excessive 
visceral adiposity. 
Future interventions 
could include the 
development of an app 
that can link the 
patient’s at-home-
measurements and 
update their WC 
measurements to the 
EMR in live time. 
Other improvements 
could be development 
of app-alerts through 
the patient portal 
system to allow for daily 
motivation and 
reminders according to 
current weight-loss & 
exercise guidelines. 
There could also be an 
“opt-in” social network 
for participants in the 
program to foster better 
adherence and support. 
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Interview Consent Forms
• Sent to clerkship staff via email to preserve anonymity. 
